Unresolved
We still don’t know whether anyone at this organisation has actually used this technology — zero lived-experience observations exist.
Not yet answered
What are we missing?
HealthAratus Intelligence
Foundation Medicine
Foundation MedicineFoundation Medicine Intelligence
What the accumulated evidence, deployment record and lived experience actually show.
Intelligence lenses
Four ways of interrogating the same reality. Each changes the question, not the subject.
Do published findings about Foundation Medicine match what happens in practice?
Still openWhether the reported magnitude holds in practice, and in which specialties it does not.
Public evidence
Foundation Medicine launches AI-powered digital tools to accelerate cancer treatment decisions
SignalHunt:deployment:Foundation Medicine
Public evidence
Foundation Medicine, Manifold Partner to Enhance FoundationInsights With AI Capabilities
SignalHunt:deployment:Foundation Medicine
Public evidence
Foundation Medicine Announces Details of Over 20 Presentations at the 2024 ASCO® Annual Meeting
SignalHunt:validation:Foundation Medicine
Public evidence
Hemispheric raises $52M for AI brain foundation model - MobiHealthNews
MobiHealthNews
Public evidence
Aidoc Secures $150M for CARE, its Healthcare Foundation Model, to Transform Clinical Decision-Making for 100 Million Patients
SignalHunt:deployment:Aidoc
What we know · what we don’t
Everything here is open to being corrected by someone who has seen it first-hand.
What we still don’t know
Nobody has answered these yet. Your experience can help us understand what is happening.
Matters of record
Settled elsewhere. Context for reading the above, not something practice can confirm.
- 28 public external signal(s) across 11 source(s).Recorded by HealthAratus
Tool intelligence
What HealthAratus understands
HealthAratus currently understands Foundation Medicine through regulatory records, deployment evidence, company records and external market activity.
- Category
- life_sciences_drug_discovery
What HealthAratus is still learning
HealthAratus is beginning to understand Foundation Medicine. As evidence and experience accumulate, what remains unclear will be stated here.
Evidence & claims
What this is built on
The material the questions above were built from, with its attribution.
Foundation Medicine provides comprehensive genomic profiling tests to analyze the genetic makeup of tumors. These tests identify genetic alterations to inform the selection of targeted cancer therapies.According to Foundation Medicine
What Foundation Medicine states
The vendor’s own claims. Testable where practice can actually test them.
Stated capability
I have used Foundation Medicine to identify genetic alterations from tumor tissue or blood samples.
According to Foundation Medicine
Does this change your workflow?
Independent and public evidence
Found in public sources. Not a clinician’s experience, and never presented as one.
Reported deployment
Foundation Medicine, Manifold Partner to Enhance FoundationInsights With AI Capabilities
Reported publicly
How widely is this actually used?
Reported deployment
Foundation Medicine Announces Details of Over 20 Presentations at the 2024 ASCO® Annual Meeting
Reported publicly
How widely is this actually used?
Reported deployment
Aidoc Secures $150M for CARE, its Healthcare Foundation Model, to Transform Clinical Decision-Making for 100 Million Patients
Reported publicly
How widely is this actually used?
Reported outcome
Foundation Medicine launches AI-powered digital tools to accelerate cancer treatment decisions
Reported publicly
Are you seeing this result?
Recent change
Hemispheric raises $52M for AI brain foundation model - MobiHealthNews
According to MobiHealthNews
Have you noticed this shift?
Company participation
Not yet verified
A record of the reality forming around this technology already exists. No representative of the company has verified participation yet.
Claim your company profileReference
The stable facts, for interpreting everything above.
Overview
What it does
-
Overview: Foundation Medicine specializes in comprehensive genomic profiling (CGP) tests that analyze the genetic makeup of tumors to inform personalized cancer treatment strategies.
-
Technical Functionality: Their flagship product, FoundationOne®CDx, examines DNA from tumor tissue to identify genetic…
Vendor & external product information, not independently verified by HealthAratus
Where it's used
Deployed in mixed settings
Key strength
Regulatory: FDA-approved companion diagnostic
Parent Company
Foundation Medicinevendor
How the reality here has changed
Earlier activity concentrated on accuracy quality. More recent activity concentrates on adoption state, time saved.
Earlier
- accuracy quality
More recently
- adoption state
- time saved
Across the category
Foundation Medicine against the rest of Life Sciences / Drug Discovery
Category intelligence reads this as Established. A sample of peers, not a census of the category.
Where Foundation Medicine may differ
Differences in what we have recorded. Never a ranking, never a quality judgement.
No first-hand account has been recorded for Foundation Medicine or for any peer we sampled in this category.
A gap across the whole category, not a fact about this technology.
Two readings that disagree
- Category intelligence reads clinical reality here as "Developing", yet no first-hand account appears in the systems we sampled. Both readings are shown rather than reconciled.
Used another system in Life Sciences / Drug Discovery? How does your experience compare?
A comparison across two systems tests the category, not just one product.
Connected intelligence
Category intelligence